Join the Daytrana group to help and get support from people like you.
Daytrana News
ADHD Meds Tied to Heart Damage in Young Adult Users
WEDNESDAY, March 27, 2024 – ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the heart muscle), and the risk grows with time,...
In Utero Rx Stimulant Exposure Not Tied to Later Neurodevelopmental Issues
THURSDAY, Feb. 1, 2024 --Amphetamine/dextroamphetamine and methylphenidate exposure in utero does not appear to increase the risk for childhood neurodevelopmental disorders, according to a study...
Seniors With ADHD Face Higher Car Crash Risk
WEDNESDAY, Oct. 4, 2023 – While studies of ADHD and driving usually target teens, a new one focused on seniors found they have a significantly higher risk of car crashes. Older adults with...
ADHD: What Parents Need to Know
MONDAY, Sept. 4, 2023 – Lots of children and adolescents have the condition known as ADHD, or attention-deficit/hyperactivity disorder. What should parents know? A number of treatments exist to help...
Counterfeit Pills Fuel Rising Number of Fatal Drug Overdoses
FRIDAY, Sept. 1, 2023 – A growing number of overdose deaths in the United States involve counterfeit pills, health officials reported Thursday. Overdose deaths involving counterfeit pills were twice...
Output of ADHD Meds Needs Boosting
WEDNESDAY, Aug. 2, 2023 – While demand for prescription stimulants is surging, a shortage of the drugs persists, so federal officials have stepped in and asked drug companies to ramp up production...
ADHD Drugs Won't Raise Risk for Illicit Drug Use Later
WEDNESDAY, July 12, 2023 – Teens who use stimulant medication like Ritalin to treat attention-deficit/hyperactivity disorder (ADHD) do not have an increased risk of illicit drug use later, a new...
Stimulant Treatment for Childhood ADHD Not Linked to Substance Use
TUESDAY, July 11, 2023 – For children with attention-deficit/hyperactivity disorder (ADHD), stimulant treatment is not associated with later frequent substance use by adolescents and young adults,...
Taking ADHD Meds Won't Raise a Kid's Odds for Drug Abuse Later: Study
THURSDAY, July 6, 2023 – Stimulant medications like Ritalin are commonly prescribed to help treat the symptoms of attention deficit hyperactivity disorder, but there have been concerns the drugs may...
FDA Medwatch Alert: FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions
What safety concern is FDA announcing? To address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants, the U.S. Food and Drug Administration (FDA) is requiring...
FDA Medwatch Alert: Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes
ISSUE: FDA is warning that permanent loss of skin color may occur with use of the Daytrana patch (methylphenidate transdermal system) for Attention Deficit Hyperactivity Disorder (ADHD). FDA added a...
FDA Medwatch Alert: Methylphenidate ADHD Medications: Drug Safety Communication - Risk of Long-lasting Erections
ISSUE: FDA is warning that methylphenidate products (including Concerta, Daytrana, Focalin/Focalin XR, Metadate CD/Metadate ER, Methylin/Methylin ER, Quillivant XR, Ritalin/Ritalin LA/Ritalin SR),...
FDA Approves Daytrana (methylphenidate transdermal system) CII for the Treatment of ADHD in Adolescents
DUBLIN and PHILADELPHIA, July 6 /PRNewswire-FirstCall/ – Shire plc , the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Attention-Deficit Hyperactivity Disorder (ADHD)